Aprogen pharmaceuticals,Inc.

KSE 003060.KS

Aprogen pharmaceuticals,Inc. Revenue for the year ending December 31, 2023: USD 67.10 M

Aprogen pharmaceuticals,Inc. Revenue is USD 67.10 M for the year ending December 31, 2023, a 30.28% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Aprogen pharmaceuticals,Inc. Revenue for the year ending December 31, 2022 was USD 51.50 M, a 8.94% change year over year.
  • Aprogen pharmaceuticals,Inc. Revenue for the year ending December 31, 2021 was USD 47.28 M, a -3.42% change year over year.
  • Aprogen pharmaceuticals,Inc. Revenue for the year ending December 31, 2020 was USD 48.95 M, a 11.55% change year over year.
  • Aprogen pharmaceuticals,Inc. Revenue for the year ending December 31, 2019 was USD 43.88 M, a 8.12% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
KSE: 003060.KS

Aprogen pharmaceuticals,Inc.

CEO Mr. Jeong-Chool Kim
IPO Date Jan. 4, 2000
Location South Korea
Headquarters Halla Sigma Valley 442-2
Employees 377
Sector Health Care
Industries
Description

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.

Similar companies

000640.KS

Dong-A Socio Holdings Co., Ltd.

USD 68.20

0.14%

005960.KS

Dongbu Corporation

USD 2.55

0.20%

003000.KS

Bukwang Pharmaceutical Co., Ltd.

USD 3.32

0.12%

003520.KS

Yungjin Pharm. Co., Ltd.

USD 1.45

1.70%

025560.KS

Mirae Corporation

USD 0.57

0.98%

StockViz Staff

January 15, 2025

Any question? Send us an email